today announced that on 8 February 2013 it received a Complete Response Letter from the US Food and Drug Administration (FDA) regarding the New Drug Applications for Tresiba ® (insulin degludec) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results